T1D Monitoring Project meeting minutes 9/25/23
T1D Screening and Monitoring Project meeting 9/25/23 4:00 PM ET
Participants: Carla Demeterco-Berggren; Laura Jacobsen; Osagie Ebekozien; Nicole Rioles; Ann Mungmode; Emma Ospelt
Minutes:
What are we most looking forward to by participating in this project?
- Sharing best practices
- Determining a workflow
- Advocating for equity (publicly insured patients)
- Prevent DKA
- EPIC integration
- Robust data analysis
Deliverables
- Participate in QI project and update prior work to quantify care team perceptions
- Support development of a change package and published manuscript
Process map sharing
- Rady shared an initial process
- How do you screen non-patients (particularly adults)
- They will need to agree to screening and billing setup
- Or send to TrialNet
- Over this project, we will explore steps for monitoring in the event patients are not interested or eligible for Tzield
- Also, ID an algorithm to determine stages of diabetes (has a family dx with T1D, positive for antibodies, etc.)
- We can invite BDC ASK program to a future call
- Rady team will invite nurse educators to future calls
- How do you screen non-patients (particularly adults)
- University of FL shared TrialNet process
- Medscape has a good piece on family perspectives that can share this with group
- Process exists, and there is room to improve
- Can take months for TrialNet to share negative result with patient
- General population is not eligible for TrialNet
- UF also has a list of ICD-10 codes that can use in place of stages of diabetes (will share with group)
- Teams can also view list of Quest labs in EMR
- JDRF guidelines should be available soon
- We can invite Anastasia O’Neill to the next call to review guidelines
- Our plan is to start data sharing in January
Next steps
- T1DX team to share meeting minutes and materials on T1DX-QI member website
- T1DX team to share times that work for a late Nov/early Dec meeting, and following Jan meeting
Meeting Recording https://protect-us.mimecast.com/s/iPrZCxkW4XsLpR9CwFoUF
This Post Has 0 Comments